## ALGN: Align Technology, Inc. - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.95 indicates fundamental undervaluation. Caution: overbought RSI (72).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($144.88)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 9, Bearish: 0)

**1. Align Technology (NASDAQ: ALGN) spotlights iTero, exocad, Invisalign at GNYDM 2025**
- Source: Stock Titan | 20251203T205500 | Bullish | Relevance: 100%
- Align Technology showcased its latest digital dentistry innovations at the Greater New York Dental Meeting (GNYDM) 2025, highlighting advancements across its Align Digital Platform, including the Invisalign system, iTero intraoral scanners, and exocad CAD/CAM software. The company featured new products like the iTero Lumina scanner and Invisalign Smile Architect, alongside educational sessions for dental professionals. These innovations aim to enhance treatment planning, practice efficiency, and patient outcomes for dental practices worldwide.

**2. Align Technology Showcases Digital Dentistry Innovations at Greater New York Dental Meeting 2025**
- Source: Morningstar | 20251203T205500 | Bullish | Relevance: 100%
- Align Technology (NASDAQ: ALGN) showcased its latest digital dentistry innovations at the Greater New York Dental Meeting 2025, highlighting advancements in its Align™ Digital Platform. Key innovations presented included the iTero Lumina™ scanner, Align™ Oral Health Suite, Invisalign Smile Architect™, iTero™ Design Suite, and ClinCheck® Signature experience, designed to enhance clinical outcomes and patient treatment. The company also sponsored clinical education sessions led by industry experts, emphasizing its commitment to advancing digital dentistry.

**3. Align Technology Strengthens Presence in South Africa with Innovative Digital Dentistry Solutions**
- Source: TechAfrica News | 20251201T113634 | Bullish | Relevance: 100%
- Align Technology is expanding its operations in South Africa to enhance support for dental practitioners across Sub-Saharan Africa. The company aims to advance digital dentistry adoption by providing access to its innovative portfolio, including the Invisalign® System, iTero™ scanners, and exocad™ software. This expansion reflects the growing trend towards digital transformation in dental care and positions Align Technology to lead the region’s digital dentistry evolution.

**4. Align Technology Inc. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251203T171800 | Bullish | Relevance: 100%
- Align Technology Inc. (ALGN) saw its stock advance by 2.70% to $155.00 on Wednesday. This strong performance occurred during a favorable trading session where the S&P 500 Index and Dow Jones Industrial Average also rose. This marks the second consecutive day of gains for Align Technology Inc.

**5. New technologies: digital innovation meets connection**
- Source: Dentistry UK | 20251203T061314 | Bullish | Relevance: 100%
- This article highlights how new digital innovations from Align Technology, such as the iTero intraoral scanner, Invisalign Outcome Simulator Pro with Smile Video, and Align Oral Health Suite, are transforming patient engagement, diagnosis, and treatment planning in dentistry. UK practitioners Dr. Raj Juneja, Dr. Jan Einfeldt, and Dr. Mumta Jilka report increased treatment acceptance and improved patient-clinician communication due to these technologies. The advancements help bridge the gap between clinical planning and emotional connection by providing clear visualizations and personalized treatment journeys.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.6% (+0.7%)
- Blackrock Inc.: 6.9% (-3.4%)
- Ninety One UK Ltd: 6.3% (+136.6%)
- Capital Internationa: 4.2% (+88.6%)
- State Street Corpora: 4.0% (-1.3%)

### Key Risks

1. High beta (1.86) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +2.3% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.95 indicates undervaluation relative to growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.5B |
| Beta | 1.86 |
| 52W Range | $122.00 - $237.23 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.95 |
| Forward P/E | 14.2 |
| Current P/E | 15.2 |
| YoY Growth | 7.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 5.6% to 8.0% (+2.3% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 92nd percentile. MRS_5 at 3.3% confirms short-term momentum alignment. AM_20 at 10.0% shows strong absolute momentum above own 20MA. Outperforming sector by 8.2pp, stock-specific strength. Below SMA200 (0.96x), long-term trend not supportive. MACD histogram positive (1.52), confirming momentum. RSI overbought at 72, risk of mean reversion. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.96% (CS: 93) | Strong |
| RSI_14 | 71.5 | Overbought |
| MACD Histogram | 1.52 | Bullish |
| vs SMA20 | 1.100x | Above |
| vs SMA50 | 1.145x | Above |
| vs SMA200 | 0.964x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $155.00
- **Stop Loss:** $144.88 (6.5% risk)
- **Target:** $175.24 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 93
- **Position Value:** $14,415.00
- **Portfolio %:** 14.41%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-04 (Est: $2.96)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.41 | $2.61 | +8.4% |
| 2025Q2 | $2.57 | $2.49 | -3.3% |
| 2025Q1 | $1.99 | $2.13 | +7.1% |
| 2024Q4 | $2.45 | $2.44 | -0.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*